Physician profile
Cameron Guild
NPI 1396771366
$4,447.45
in general payments reported to CMS, 2019-2025
27 companies · $509 in 2025
The $509 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,164 · 2020: $581 · 2021: $791 · 2022: $638 · 2023: $178 · 2024: $587 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,147.70 | 2019-2023 | Impella |
| Novartis Pharmaceuticals Corporation | $322.96 | 2019-2025 | |
| Abbott Laboratories | $212.03 | 2019-2025 | Gallant, Perclose Prostyle |
| Boston Scientific Corporation | $181.21 | 2024-2025 | Ingevity+, Watchman Access System, General - Therapies |
| Inari Medical, INC. | $149.92 | 2021-2022 | |
| Novo Nordisk INC | $126.72 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.44 | 2021-2022 | |
| Heartflow, INC. | $120.77 | 2024 | |
| Lantheus Medical Imaging, INC. | $119.59 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $117.70 | 2024-2025 | Wainua, Breztri |
| Chiesi USA, INC. | $111.48 | 2025 | Kengreal |
| Idorsia Pharmaceuticals US INC | $108.16 | 2025 | Tryvio |
| Pfizer INC. | $102.92 | 2019-2025 | |
| Btg International INC. | $100.80 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $91.77 | 2025 | Evkeeza |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $59.87 | 2022-2023 | Eliquis |
| Gilead Sciences, INC. | $46.79 | 2019 | |
| Cardiovascular Systems INC. | $31.75 | 2019 | |
| Impulse Dynamics (USA) INC. | $29.52 | 2023 | Optimizer |
| Amgen INC. | $24.19 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $23.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.14 | 2025 | |
| Medtronic, INC. | $17.74 | 2024 | Micra |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.99 | 2024 | Xarelto |
| Arbor Pharmaceuticals, INC. | $12.77 | 2019 | |
| Ge Healthcare | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Guild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.